A new trading day began on Monday, with Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) stock price down -4.47% from the previous day of trading, before settling in for the closing price of $0.70. QNRX’s price has ranged from $0.43 to $6.18 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 78.42%. With a float of $1.12 million, this company’s outstanding shares have now reached $5.05 million.
Considering the fact that the conglomerate employs 4 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 50.81%, operating margin of -5948.33%, and the pretax margin is -5648.18%.
Quoin Pharmaceuticals Ltd ADR (QNRX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The most recent insider transaction that took place on Dec 23 ’24, was worth 250,000. In this transaction Chief Operating Officer of this company bought 555,556 shares at a rate of $0.45, taking the stock ownership to the 602,648 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Executive Officer bought 555,556 for $0.45, making the entire transaction worth $250,000. This insider now owns 602,808 shares in total.
Quoin Pharmaceuticals Ltd ADR (QNRX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 78.42% per share during the next fiscal year.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Trading Performance Indicators
Here are Quoin Pharmaceuticals Ltd ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.08, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Quoin Pharmaceuticals Ltd ADR (QNRX)
Compared to the last year’s volume of 0.99 million, its volume of 0.96 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 68.94%. Additionally, its Average True Range was 0.11.
During the past 100 days, Quoin Pharmaceuticals Ltd ADR’s (QNRX) raw stochastic average was set at 21.31%, which indicates a significant decrease from 63.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 161.20% in the past 14 days, which was higher than the 149.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6769, while its 200-day Moving Average is $0.6672. Nevertheless, the first resistance level for the watch stands at $0.7287 in the near term. At $0.7883, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8377. If the price goes on to break the first support level at $0.6197, it is likely to go to the next support level at $0.5703. Should the price break the second support level, the third support level stands at $0.5107.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Key Stats
With a market capitalization of 3.38 million, the company has a total of 5,050K Shares Outstanding. Currently, annual sales are 0 K while annual income is -8,690 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,350 K.
